Several cases of bullous pemphigoid and bullous pemphigoid-like skin lesions have been described in patients under treatment with anti-PD-1 agents [45–48], whereas rare cases of bullous skin lesions have been reported after anti-CTLA-4 antibodies [49, 50]. Here, PDCD1 is linked to bullous pemphigoid.